Outcome differences between recanalized malignant central airway obstruction from endoluminal disease versus extrinsic compression
- 12 November 2018
- journal article
- research article
- Published by Springer Nature in Lasers in Medical Science
- Vol. 34 (5) , 955-962
Abstract
We compared the outcome of Nd:YAG laser therapy with stent placement for malignant central airway obstruction (CAO) at our center over a 10-year period. This is a retrospective review of patients undergoing Nd:YAG laser therapy or self-expanding metal stent (SEMS) placement for malignant CAO between November 2007 and October 2017. Seventy-two patients were recanalized for malignant CAO. The median (range) age was 63 (23–86) years, with 49 (68%) males. Patients underwent either laser therapy alone (N = 36), stent placement alone (N = 30), or both (N = 6). The wavelength of Nd:YAG laser used was 1064 nm, and median (range) laser energy used was 25 (15–35) W, in 377 (115–1107) pulses. Fifty-one (71%) patients died with median survival of 7.2 months. In subgroup analysis, 21 (58.3%) vs. 25 (83.3%), p = 0.03 patients died in the “laser resection” vs. “stent placement” group with longer median survival of 12.4 months in the former vs. 4.5 months, p = 0.0004 in the later. Esophageal cancer and left main bronchus involvement were significantly more common (10 (33.3%) vs. 0, p = 0.0001, and 16 (53.3%) vs. 8 (22.2%), p = 0.01), in the stent placement vs. laser resection group, respectively. Trachea or main bronchi involvement and respiratory failure on presentation requiring mechanical ventilation correlated with poorer survival. The immediate restoration of luminal patency, complication rate, and 30-day mortality was similar among the two groups. The median (range) energy used for laser therapy was 25 (15–35) W. Median of 377 pulses was used for the duration of 287.5 s. The results were compared using a Wilcoxon two-sample test, and Fischer exact test with p values considered indicative of a significant difference if less than 0.05. In patients requiring recanalization of malignant CAO, the extrinsic compression from esophageal cancer, trachea or main bronchi involvement, respiratory failure on presentation requiring mechanical ventilation, and stent placement correlated with poorer survival. Interventional pulmonology training program should emphasize on dedicated training in laser therapy as it is associated with improved survival.Keywords
This publication has 18 references indexed in Scilit:
- Therapeutic Bronchoscopy for Malignant Central Airway ObstructionChest, 2015
- Usefulness of Rigid Bronchoscopic Intervention Using Argon Plasma Coagulation for Central Airway TumorsClinical and Experimental Otorhinolaryngology, 2015
- Clinical aspects and treatment of primary tracheal malignanciesActa Oto-Laryngologica, 2010
- Therapeutic bronchoscopy for malignant airway stenoses: Choice of modality and survivalJournal of Cancer Research and Therapeutics, 2010
- Laser Ablation of Metastatic Lesions of the Lung: Long-Term OutcomeAmerican Journal of Roentgenology, 2009
- Impact of Interventional Bronchoscopy on Quality of Life in Malignant Airway ObstructionRespiration, 2008
- Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration AdvisoryChest, 2007
- Central Airway ObstructionAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Use of Studded Polyflex™ Stents in Patients with Neoplastic Obstructions of the Central AirwaysRespiration, 2004
- Endoscopic Treatment of Malignant Airway Obstructions in 2,008 PatientsChest, 1996